Recovered COVID-19 patients’ plasma: what is this experimental therapy?
On Saturday, the Houston Methodist Hospital took blood from a patient who had recovered from COVID-19 two weeks ago, and infused it into another critically ill patient. It was a first for the US; the hospital’s blood bank now plans to collect blood from at least 250 recovered COVID-19 patients.
With no specific treatment available for novel coronavirus disease and a vaccine at least a year away, the US Food and Drug Administration (FDA) last week approved use of blood plasma from recovered patients to treat severely critical COVID-19 patients.
Indian express
